Retatrutide

What the peptide is: Retatrutide represents the absolute cutting edge of metabolic therapy as a single-molecule, triple hormone receptor agonist. It is chemically engineered to simultaneously activate the GLP-1, GIP, and glucagon receptors. Like its predecessors, it possesses a C20 fatty diacid tail to prolong its biological half-life, allowing for convenient once-weekly dosing while orchestrating a massive systemic metabolic shift.